Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Laurantis Pharma Oy
OY
Active
Y-tunnus 2210546-0
Itäinen Pitkäkatu 4B, 20520
Turku
Muu luonnontieteellinen ja tekninen tutkimus ja kehitt.
·
NACE 72190
Est. 2008 · 17 years old
— employees
www.laurantis.com
Share
Finland
/
Companies
/
Muu luonnontieteellinen ja tekninen tutkimus ja kehitt.
/
Laurantis Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
EBITDA
EUR millions
0M
-1M
-1M
-2M
-3M
-1M
2018
-2M
-100%
2019
-1M
+50%
2020
-1M
0%
2021
Income statement
EUR thousands
Item
2018
2019
2020
2021
Revenue
0
0
0
0
Staff expenses
—
—
—
—
EBITDA
−847
−1 536
−1 314
−851
Depreciation & amort.
−0
−0
—
—
EBIT
−848
−1 537
−1 314
−851
Net financials
−165
−24
−24
−16
Profit before tax
−1 012
−1 561
−1 338
−867
Tax
−0
−0
−0
−0
Net profit
−1 012
−1 561
−1 338
−867
Balance sheet
EUR thousands
Item
2018
2019
2020
2021
Total assets
227
524
732
844
Equity
−5 383
−6 945
−8 282
−9 150
Long-term debt
5 096
7 414
8 675
9 275
Short-term debt
515
54
339
719
Total debt
5 610
7 468
9 014
9 993
Financial ratios
5-year trend
EBITDA-margin
-85102500.0%
This company
15.8%
Market median
-538623518% vs market
2018
2021
Soliditetsgrad
-1084.5%
This company
38.2%
Market median
-2939% vs market
2018
2021
Egenkapitalforrentning
-86705000.0%
This company
18.4%
Market median
-471222926% vs market
2018
2021
Nettoresultatgrad
-86705000.0%
This company
8.1%
Market median
-1070432199% vs market
2018
2021
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2018
2021
Gæld/egenkapital
1.09×
This company
0.62×
Market median
-76% vs market
2018
2021
Annual reports & filings
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
View
PDF
More on Laurantis Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
